More than 75 Florida firms are going to share more than $26 million in federal tax credits or grants, 40 of them in South Florida alone.
The awards were part of the Qualifying Therapeutic Discovery Project Program and the national healthcare overhaul. That program encouraged companies with fewer than 250 employees to apply and who could show significant potential to produce new cost-saving therapies, create U.S. jobs and increase the nation's competitiveness while advancing the goal of curing cancer within the next 30 years, according to an Associated Press report.
The maximum credit is $5 million per firm with 250 or fewer employees.
The announcement was made by BioFlorida, an industry group which represents 200 companies and research organizations in the biotechnology, pharmaceutical and medical device fields.
The awards were part of the Qualifying Therapeutic Discovery Project Program and the national healthcare overhaul. That program encouraged companies with fewer than 250 employees to apply and who could show significant potential to produce new cost-saving therapies, create U.S. jobs and increase the nation's competitiveness while advancing the goal of curing cancer within the next 30 years, according to an Associated Press report.
The maximum credit is $5 million per firm with 250 or fewer employees.
The announcement was made by BioFlorida, an industry group which represents 200 companies and research organizations in the biotechnology, pharmaceutical and medical device fields.
The program awarded up to $244,479.25 per application. The credit or grant can cover up to 50 percent of the cost of biomedical research expenses that qualify. The maximum credit is $5 million per firm, and $1 billion for the program nationwide.
South Florida businesses benefitting from the Qualifying Therapeutic Discovery Project Program are:
Venx LLC, Boca Raton
Mergenet Medical, Inc., Coconut Creek
Catalyst Pharmaceutical Partners, Inc., Coral Gables
Nutra Pharma Corporation, Coral Springs
Aspiration Medical Technology, LLC, Davie
Linguaflex, Inc., Davie
Concordia Pharmaceuticals, Inc., Ft. Lauderdale
LifeSync Corporation, Ft. Lauderdale
Orbus Neich Medical, Inc., Ft. Lauderdale
Precision Medical Devices, Inc., Ft. Lauderdale
GeneEx, Inc., Hialeah
Adhaere Pharmaceuticals, Inc., Miami
Aquatrove Biosciences, Inc., Miami
Bio-Nucleonics, Inc., Miami
CHS Resources, LLC, Miami
Converge Biotech, Inc., Miami
Dharma Biomedical, LLC, Miami
Heat Biologics, Inc., Miami Beach
InnFocus LLC, Miami
Ivax Diagnostics, Inc., Miami
Metabogenix Technologies, Inc., Miami
OPKO Pharmaceuticals, LLC, Miami
Pioma Inc., Miami
SafeStitch Medical, Inc., Miami
Skeletal Dynamics, LLC, Miami
Syntheon, LLC, Miami
Tele Home Care Solutions Company, Miami
Tissuetech, Inc., Miami
Altor Bioscience Corporation, Miramar
Altor Bioscience Corporation, Miramar
Eyetech, Inc., Palm Beach Gardens
Ocean Ridge Biosciences, LLC, Palm Beach Gardens
Accu-Break Pharmaceuticals Inc., Plantation
Bioheart, Inc., Sunrise
Cytorex Biosciences, Inc., Weston
ParinGenix, Inc., Weston
iSense, LLC, West Palm Beach
Rose Pharmaceuticals, LLC, West Palm Beach
Tyrogenex Inc., West Palm Beach
Winprobe Corporation, West Palm Beach
Xcovery Holding Company LLC, West Palm Beach
Source: Cbs4
No comments:
Post a Comment